» Articles » PMID: 35687517

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Increased Risk of Developing Psychiatric Disorders: A Retrospective Population-based Cohort Study in Taiwan

Overview
Journal J Dermatol
Specialty Dermatology
Date 2022 Jun 10
PMID 35687517
Authors
Affiliations
Soon will be listed here.
Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening adverse reactions to drugs and psychological sequelae are also observed to follow the trauma of widespread epidermal necrolysis. To delineate the association between SJS and TEN, and psychiatric disorders, we conducted a retrospective population-based cohort study by including 212 patients diagnosed with first-time SJS or TEN in Taiwan between 2000 and 2013 and 669 population controls. Adjusted hazard ratios were calculated after adjusting for sex, age, comorbidity in the form of Charlson comorbidity index, and facility level of care. Overall, SJS or TEN was associated with an increased risk of developing psychiatric disorders including schizophrenia, major depressive disorder, mania, anxiety, and bipolar with an adjusted hazard ratio of 1.392 (95% CI, 1.192-1.625; p < 0.001). Particularly, the adjusted hazard ratios of psychiatric disorders were 1.290 (95% CI, 1.105-1.506; p < 0.001) for SJS and 1.855 (95% CI, 1.587-2.167; p < 0.001) for TEN.

Citing Articles

Comparing pharmacists versus allergists in low-risk penicillin allergy delabelling: The Hong Kong Penicillin Allergy Pharmacist Initiative (HK-PAPI).

Hooi J, Low M, To J, Mak H, Choi M, Tam C World Allergy Organ J. 2024; 17(12):101003.

PMID: 39640898 PMC: 11617727. DOI: 10.1016/j.waojou.2024.101003.


Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.

Cadot R, Gery P, Lenief V, Nicolas J, Vocanson M, Tauber M Allergy. 2024; 80(1):47-62.

PMID: 39295209 PMC: 11724259. DOI: 10.1111/all.16316.


Psychiatric comorbidities on an inpatient dermatology consultation service: A cross-sectional analysis.

Norman T, Guenther J, Vecerek N, Adler B, Crew A, Worswick S Skin Health Dis. 2023; 3(5):e266.

PMID: 37799370 PMC: 10549832. DOI: 10.1002/ski2.266.